SAN FRANCISCO, June 29, 2017 /PRNewswire/ --
The global molecular biology enzymes and kits & reagents market is expected to reach USD 26.7 billion by 2025, according to a new report by Grand View Research, Inc. Expanding pharmaceutical and biotechnology industry in emerging nations is expected to offer significant growth opportunities to the molecular biology enzymes, kits, and reagents market. Furthermore, the increasing adoption of personalized medicine is expected to provide lucrative opportunities to the market.
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO)
Technological advancements aimed at development of advanced products and increasing R&D investments by leading manufacturers are some of the key factors contributing to increasing demand for these enzymes, kits, and reagents. In addition, increasing adoption of molecular diagnostics is expected to serve this industry as a potential growth driver.
Molecular biology enzymes, kits, and reagents are majorly used in genomics-related application areas. Increased funding for research in the field of genomics and sequencing are expected to augment growth during the forecast period. Furthermore, these products are used in the drug discovery and development stages in pharmaceutical and biopharmaceutical companies.
Pharmaceutical and biotechnology companies contribute to the largest share of the end users of molecular biology enzymes, kits, and reagents. This dominant share can be attributed to increasing investments in R&D, expanding biopharmaceutical & biotechnology industry in the Asia Pacific region, and government initiatives in various countries to develop the biotechnology & pharmaceutical industry.
Browse full research report with TOC on "Molecular Biology Enzymes And Kits & Reagents Market Analysis By Product (Kits and Reagents, Enzymes), By Application (PCR, Sequencing, Cloning, Epigenetics), By End User, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/molecular-biology-enzymes-kits-reagents-market
Further key findings from the report suggest:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
Advertisement
The global molecular biology enzymes and kits & reagents market is expected to reach USD 26.7 billion by 2025, according to a new report by Grand View Research, Inc. Expanding pharmaceutical and biotechnology industry in emerging nations is expected to offer significant growth opportunities to the molecular biology enzymes, kits, and reagents market. Furthermore, the increasing adoption of personalized medicine is expected to provide lucrative opportunities to the market.
Advertisement
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO)
Technological advancements aimed at development of advanced products and increasing R&D investments by leading manufacturers are some of the key factors contributing to increasing demand for these enzymes, kits, and reagents. In addition, increasing adoption of molecular diagnostics is expected to serve this industry as a potential growth driver.
Molecular biology enzymes, kits, and reagents are majorly used in genomics-related application areas. Increased funding for research in the field of genomics and sequencing are expected to augment growth during the forecast period. Furthermore, these products are used in the drug discovery and development stages in pharmaceutical and biopharmaceutical companies.
Pharmaceutical and biotechnology companies contribute to the largest share of the end users of molecular biology enzymes, kits, and reagents. This dominant share can be attributed to increasing investments in R&D, expanding biopharmaceutical & biotechnology industry in the Asia Pacific region, and government initiatives in various countries to develop the biotechnology & pharmaceutical industry.
Browse full research report with TOC on "Molecular Biology Enzymes And Kits & Reagents Market Analysis By Product (Kits and Reagents, Enzymes), By Application (PCR, Sequencing, Cloning, Epigenetics), By End User, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/molecular-biology-enzymes-kits-reagents-market
Further key findings from the report suggest:
- Kits and reagents held the dominant share of market, by product, as of 2016 owing to their low costs and incessant product launches
- Rising number of research activities in molecular biology application areas amongst the end users is one of the key contributing factors responsible for the dominance of this product
- The Polymerase Chain Reaction (PCR) segment is expected to witness lucrative growth in the near future owing to the benefits associated with its use in molecular diagnostics
- PCR is used in detection and identification of genetic disorders. Rising geriatric population across the globe is also expected to drive this market owing to the use of PCR in detecting and diagnosing geriatric disorders.
- Rising demand for personalized medicine fosters the demand for sequencing, which further increases the demand for these enzymes, kits, and reagents
- Pharmaceutical and biotechnology companies held a dominant share, by end user in 2016
- Rising investments in R&D, expanding pharmaceutical & biotechnology industry, and increasing venture capital investments are some of the major factors contributing to the growth of this segment
- Recombinant DNA Technology Market - http://www.grandviewresearch.com/industry-analysis/recombinant-dna-technology-market
- Epigenetics Drugs and Diagnostic Technologies Market - http://www.grandviewresearch.com/industry-analysis/epigenetics-drugs-and-diagnostic-technologies-market
- Prokaryotic Expression Systems Market - http://www.grandviewresearch.com/industry-analysis/prokaryotic-expression-systems-market
- Eukaryotic Expression Systems Market - http://www.grandviewresearch.com/industry-analysis/eukaryotic-expression-systems-market
- Molecular Biology Enzymes, Kits, and Reagents Product Outlook (Revenue, USD Million, 2014 - 2025)
- Kits and Reagents
- Enzymes
- Molecular Biology Enzymes, Kits, and Reagents Application Outlook (Revenue, USD Million, 2014 - 2025)
- PCR
- Sequencing
- Cloning
- Epigenetics
- Restriction Digestion
- Synthetic Biology
- Other Applications
- Molecular Biology Enzymes, Kits, and Reagents Application Outlook (Revenue, USD Million, 2014 - 2025)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Diagnostic Centers
- Other End Users
- Molecular Biology Enzymes, Kits, and Reagents Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- MEA
- South Africa
- North America
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] Web: http://www.grandviewresearch.com
SOURCE Grand View Research, Inc.
